ストックスクリーナーアプリを入手
23.93
7.39%
-1.91
アフターアワーズ：
24.09
0.16
+0.67%
前日終値:
$25.84
開ける：
$25.54
24時間の取引高:
1.89M
Relative Volume:
0.87
時価総額：
$1.15B
収益：
-
当期純損益:
$-97.22M
株価収益率:
-10.93
EPS:
-2.19
ネットキャッシュフロー:
$-82.44M
1週間 パフォーマンス:
-9.77%
1か月 パフォーマンス:
-11.63%
6か月 パフォーマンス:
+8.53%
1年 パフォーマンス:
+5.42%
1日の値動き範囲:
$23.45
$25.70
1週間の範囲:
$23.45
$26.70
52週間の値動き範囲:
$8.79
$42.20
Cassava Sciences Inc Stock (SAVA) Company Profile
名前
Cassava Sciences Inc
セクター
電話
512-501-2444
住所
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-11-16 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | 繰り返されました | Maxim Group | Buy |
| 2021-04-27 | 開始されました | B. Riley Securities | Buy |
| 2021-02-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-23 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-09-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-01-10 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Cassava Sciences Inc (SAVA) 最新ニュース
Cassava Sciences (NASDAQ:SAVA) Trading Down 5.8%Should You Sell? - MarketBeat
Unpacking the Latest Options Trading Trends in Cassava Sciences - Benzinga
Analysts Believe Cassava Sciences Now Has 300% Upside From Here - MSN
Cassava Sciences (SAVA) Scheduled to Post Earnings on Thursday - MarketBeat
Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024 - GlobeNewswire
International Assets Investment Management LLC Makes New Investment in Cassava Sciences, Inc. (NASDAQ:SAVA) - MarketBeat
Institutions along with individual investors who hold considerable shares inCassava Sciences, Inc. (NASDAQ:SAVA) come under pressure; lose 6.7% of holdings value - Yahoo Finance
Long Term Trading Analysis for (SAVA) - Stock Traders Daily
Cassava Sciences Inc (SAVA-Q) QuotePress Release - The Globe and Mail
HC Wainwright & Co. Upgrades Cassava Sciences (SAVA) - MSN
Cassava Sciences Options Trading: A Deep Dive into Market Sentiment - Benzinga
Institutions profited after Cassava Sciences, Inc.'s (NASDAQ:SAVA) market cap rose US$72m last week but individual investors profited the most - Simply Wall St
(SAVA) Proactive Strategies - Stock Traders Daily
Cassava Sciences, Inc. (SAVA): Jim Cramer Says Eli Lilly Has The Edge - Insider Monkey
Cassava Sciences (NASDAQ:SAVA) Trading 5.1% HigherWhat's Next? - MarketBeat
HC Wainwright Comments on Cassava Sciences, Inc.'s FY2025 Earnings (NASDAQ:SAVA) - MarketBeat
After Cassava Fraud Indictment, Questioning the Ethics of Simufilam Trial - Being Patient
Cassava Sciences Advances Alzheimer’s Trials Amid SEC Settlement - Yahoo Finance
Cassava Sciences: Phase III trials storm ahead amid controversy - Yahoo Finance
(SAVA) Long Term Investment Analysis - Stock Traders Daily
Cassava Sciences Stock Jumps After CEO’s Update On Alzheimer’s Drug Trial: Retail Sentiment Wavers - Barchart
Crude Oil Falls Over 4%; US Trade Deficit Narrows In August - Benzinga
Cassava Sciences (NASDAQ:SAVA) Shares Gap UpTime to Buy? - MarketBeat
What's Going On With Alzheimer's-Focused Cassava Sciences On Tuesday? - Benzinga
Cassava Sciences earns rare buy as H.C. Wainwright upgrades post settlement - MSN
Why Is Bio-Path Holdings Stock Soaring On Tuesday?Cassava Sciences (NASDAQ:SAVA) - Benzinga
Cassava Sciences stock upgraded at H.C. Wainwright (NASDAQ:SAVA) - Seeking Alpha
Cassava Sciences (NASDAQ:SAVA) Lifted to Buy at HC Wainwright - MarketBeat
Cassava agrees to $40M settlement over misleading Alzheimer’s clinical trial statements - Top Class Actions
An Alzheimer’s drugmaker is accused of data manipulation. Should its trials be stopped? - BioPharma Dive
Cassava's Alzheimer's Therapy: A Confidence Bet - Seeking Alpha
SEC brings securities fraud charges against Cassava Sciences - JD Supra
Cassava Sciences, enVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session - MSN
SAVA Stock Down On Settling Misleading Alzheimer's Study Data Claims - Barchart
SAVA Stock Down on Settling Misleading Alzheimer's Study Data Claims - Zacks Investment Research
Company News for Sep 30, 2024 - Yahoo Finance
SEC charges Cassava over 'misleading' Alzheimer's claims - pharmaphorum
These Stocks Are Moving the Most Today: Bristol Myers, Costco, EchoStar, Cassava Sciences, Trump Media, and More - MSN
Cassava Sciences Sees Unusually Large Options Volume (NASDAQ:SAVA) - MarketBeat
Why Cassava Sciences Stock Dived by Almost 11% Today - MSN
(SAVA) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Stocks to Watch Friday: Bristol-Myers Squibb, Costco, Cassava Sciences, EchoStar - The Wall Street Journal
Cassava Sciences shares drop in pre-open trade after $40 mln SEC settlement - MSN
Bristol Myers, Costco, EchoStar, DJT, Wynn, HP Inc., and More Stock Movers - Barron's
Cassava Sciences agrees to $40M SEC fine over Alzehimer's claims - Yahoo Finance
Stocks making the biggest moves midday: Wynn Resorts, Rocket Lab USA, Cassava Sciences and more - CNBC
Cassava Sciences (NASDAQ:SAVA) Shares Gap Down to $31.87 - MarketBeat
Cassava Sciences Inc (SAVA) 財務データ
収益
当期純利益
現金流量
EPS
Cassava Sciences Inc (SAVA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Barry Richard | Director |
Apr 23 '24 |
Option Exercise |
22.00 |
176,085 |
3,873,870 |
469,562 |
| Kupiec James William | Chief Medical Officer |
Apr 18 '24 |
Option Exercise |
22.00 |
1,500 |
33,000 |
4,000 |
| Schoen Eric | Chief Financial Officer |
Apr 17 '24 |
Option Exercise |
22.00 |
1,500 |
33,000 |
21,300 |
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):